FDAHealthJuly 18, 2025
AEQUITA PHARMACY — Tirzepatide + Niacinamide 4.4 mg + 1.0mg/0.5 mL Inj Sol, Inject 0.5 mL (50 units on syringe) subcutaneously, Sterile, 2 mL Multi Dose Vial, Refrigerate, Do not freeze, Aequita Pharm
⚠️ Lack of Processing Controls.
Is this relevant to me?
- Geography
- MA
- Source agency
- FDA
- Category
- Health
- Published
- July 18, 2025
MA
What's affected?
- Product
- Tirzepatide + Niacinamide 4.4 mg + 1.0mg/0.5 mL Inj Sol, Inject 0.5 mL (50 units on syringe) subcutaneously, Sterile, 2 mL Multi Dose Vial, Refrigerate, Do not freeze, Aequita Pharmacy LLC, Kirkland, WA 98034.
- Brand
- AEQUITA PHARMACY
- Lot code
- within
Additional details
All Lots within expiry.
What should I do?
Recommended action
Class II recall. Voluntary: Firm initiated Quantity affected: 170 vials.
Get Health recall alerts
Delivered to your inbox. Free. No account required.